Literature DB >> 11890375

Evolution of NCEP guidelines: ATP1-ATPIII risk estimation for coronary heart disease in 2002. National Cholesterol Education Program.

C Richard Conti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11890375      PMCID： PMC6654455          DOI： 10.1002/clc.4960250302

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN： 0160-9289            Impact factor:   2.882


× No keyword cloud information.
  3 in total

1.  Evaluation of cardiovascular risk in blood donors: results of the CARDIORISK study in the Parma Transfusion Service.

Authors:  Paolo Dell'anna; Daniela Adorni; Gino Bernuzzi; Stefano Cantarelli; Alberto Cepparulo; Tiziano Cocchi; Loretana Dell'anna; Alessandro Formentini; Maria Sassi; Fiorella Scognamiglio; Maurizio Vescovi; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

2.  Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9.

Authors:  Nageshwar R Budha; Maya Leabman; Jin Y Jin; D Russell Wada; Amos Baruch; Kun Peng; Whittemore G Tingley; John D Davis
Journal:  AAPS J       Date:  2015-03-31       Impact factor: 4.009

3.  Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV.

Authors:  P G Talwalkar; C G Sreenivas; Ashish Gulati; Hemang Baxi
Journal:  Indian J Endocrinol Metab       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.